NCT00473928View on ClinicalTrials.gov

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

POT-4

Single intravitreal injection.

Trial Locations (6)

32610

United States, Florida, Gainesville

33136

United States, Florida, Miami

55905

United States, Minnesota, Rochester

85704

United States, Arizona, Tucson

90211

United States, California, Beverly Hills

03801

United States, New Hampshire, Portsmouth

Sponsors
All Listed Sponsors
lead

Potentia Pharmaceuticals, Inc.

INDUSTRY